Griet Vanpoucke, PhD, is Head New Ventures at VIB. With her team she translates exciting science from the research institute into successful novel ventures. She currently also serves as non-exec Director on the Board of Orionis Biosciences. Previously she was part of Pronota, a biomarker discovery and diagnostics start-up company. As Director R&D she was responsible for several internal and partnered biomarker discovery programs. She played a leading role in the companies transformation from a proteomics discovery company to a diagnostic product company, up and till the company was acquired in 2014. She holds a PhD in Biotechnology from Ghent University and did a postdoc at the MRC in Edinburgh, UK.
Current role